fbpx
close read more
News

Servier rewarded at the 2019 European Lifestars Awards

26/11/2019

Servier rewarded at the 2019 European Lifestars Awards

On 19 November, the Servier group won the M&A DEAL OF THE YEAR award, during the European Lifestars Awards ceremony in London, for last year’s acquisition of Shire’s Oncology branch.

This prestigious award recognizes the teams and organizations who have executed a truly transformational and high-value M&A deal for both the company and the wider pharmaceutical industry.

 

The annual European Lifestars Awards bring together hundreds of European life science leaders, investors, partners and deal makers.

“It is an honour to receive this distinction from leading investors and pharma key stakeholders. It makes the Servier teams very proud”, says Olivier Laureau, President of Servier. “The acquisition of Shire’s Oncology branch was a major step in achieving the Servier group’s ambition. It marked the launch of Servier’s commercial activities in the world’s largest pharmaceutical market – the United States – and significantly strengthened our portfolio of oncology drugs. It was part of Servier’s twofold strategy: to continue to treat an increasing number of patients with innovative medications across the world and become a world reference in oncology.”

Servier was also finalist in two other categories: Deal of the Year (<500M£) and Pharma BD team of the Year.

More information about Lifestars Awards 

Last news

News
23/06/2022
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
News
15/06/2022
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
News
01/06/2022
Patient associations’ perception of pharmaceutical companies: Servier is making progress!